Dive Brief:
Yale New Haven Health is restructuring and consolidating its leadership team, the system told Healthcare Dive on Monday.
A spokesperson for the New Haven, Connecticut-based nonprofit provider said inpatient operations will flow through the hospital’s nursing leadership. Ambulatory operations, including provider-based locations, Northeast Medical Group and Yale Medicine sites, will be directed by the system’s chief ambulatory officer and the chief ambulatory physician executive.
While most employees impacted by the reorganization will be offered new roles, up to 38 employees in management and administrative roles may be laid off due to the restructure, the spokesperson said.
Dive Insight:
Yale New Haven, which operates five hospitals in Connecticut, New York and Rhode Island, is the latest health system to announce a restructuring.
A spokesperson for Yale New Haven said their reshuffle should allow the provider to be more “nimble.”
In January, Renton, Washington-based Providence also reorganized its executive team. The reorganization involved cutting roles and creating a new Office of Transformation, which will oversee the nonprofit health system’s artificial intelligence strategy.
Last month, Novant Health moved to a regional reporting structure for its executive team, with Charlotte, Triad, Coastal and South Carolina regions each reporting to their own president.
Mass General Brigham has also trimmed executive roles, consolidating the chief medical officer function across its academic health centers last month. The news comes amid a larger push to have MGB’s largest academic hospitals, Massachusetts General and Brigham and Women’s, integrate to more efficiently share resources.
Going into 2025, analysts predicted that efficiency would be top of mind for health systems as they look to remain profitable amid rising cost pressures and an uncertain operating environment.
As the year has progressed, pressure to cut costs has intensified to get ahead of possible headwinds, including the looming threat of Medicaid cuts and how potential changes to international trade relations could impact providers.
